INHIBRX
Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The Inhibrx pipeline is focused on oncology, orphan diseases and infectious diseases. Inhibrx has collaborations with Celgene and bluebird bio and has received awards from several granting agencies, including NIH, NIAID and CARB-X.
INHIBRX
Industry:
Biotechnology Therapeutics
Founded:
2010-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.inhibrx.com
Total Employee:
51+
Status:
Active
Total Funding:
69.59 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Employees Featured
Founder
Stock Details
Investors List
RA Capital Management
RA Capital Management investment in Convertible Note - Inhibrx
Alexandria Venture
Alexandria Venture investment in Convertible Note - Inhibrx
Lilly Asia Ventures
Lilly Asia Ventures investment in Convertible Note - Inhibrx
ArrowMark Partners
ArrowMark Partners investment in Convertible Note - Inhibrx
WuXi Biologics
WuXi Biologics investment in Convertible Note - Inhibrx
Viking Global Investors
Viking Global Investors investment in Convertible Note - Inhibrx
CARB-X
CARB-X investment in Grant - Inhibrx
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - Inhibrx
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-28 | Inhibrx Strengthens Leadership Team with Three Key Executive Hires and Announces Appointment of Kristiina Vuori, M.D., Ph.D. to its Board of Directors |
Official Site Inspections
http://www.inhibrx.com Semrush global rank: 2.76 M Semrush visits lastest month: 5.86 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
